首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 140 毫秒
1.
目的结合常规羊水穿刺核型分析、荧光原位杂交(FISH)及染色体微阵列分析(CMA)对一平衡易位家系多发畸形胎儿进行产前诊断。方法对孕妇羊水穿刺进行核型分析后,再补充进行FISH及CMA对胎儿的全基因进行检测。结果孕妇及其父亲均系4号染色体与15号染色体平衡易位,胎儿染色体核型为46,XN,t(1;15)(q21;q26.3),FISH未见异常,CMA提示胎儿4q28.3?q35.2染色体片段约59 Mb的重复,以及15q26.3染色体约2.4 Mb的缺失。结论将核型分析与CMA结合,可以减少误诊和漏诊,有较好的临床应用价值。  相似文献   

2.
目的:探讨胎儿染色体核型及染色体微阵列分析(chromosome microarray analysis,CMA)在颈部透明层(nuchal translucency,NT)异常胎儿中的应用价值。方法:按NT异常是否合并其他指标异常,分为单纯NT异常、NT异常合并超声异常、NT异常合并高龄、NT异常合并不良孕产史、NT异常合并唐氏综合征产前筛查指标异常、胎儿颈部水囊瘤及孕14周后胎儿颈部皮肤厚度异常,回顾性分析其介入性产前诊断结果。结果:单纯NT异常组中,胎儿非整倍体及CMA检出率分别为1.887%、13.208%。胎儿颈部水囊瘤组胎儿非整倍体及CMA检出占比最高,分别为42.857%、28.570%。胎儿非整倍体中21三体及45, X检出占比最高,分别为5.279%、1.173%;共检出48例胎儿染色体微缺失/微重复,其中致病性及可能致病性染色体拷贝数变异占25.000%,22q11.21片段重复综合征最常见。311例正常核型中,CMA能多检出15.434%拷贝数异常。结论:面临同样的取样风险时,应告知孕妇CMA产前检测技术手段优势,并建议NT异常胎儿行染色体微阵列分析。  相似文献   

3.
目的:探讨微阵列芯片技术在产前颈项透明层(NT)增厚胎儿中的应用价值。方法:收集220例产前NT增厚(NT≥2.5 mm)的胎儿,应用单核苷酸多态性微阵列芯片(SNP array)技术检测胎儿染色体拷贝数变异(CNVs),同时进行染色体核型分析。结果:在220例NT增厚胎儿中,染色体核型分析检出32例异常,异常率为14.5%,数目异常占87.5%,结构异常占12.5%,其中21三体最常见(占43.8%),其次是18三体(占21.9%)。SNP array技术在染色体核型分析正常的胎儿中另检出9例异常CNVs,为5例致病性CNVs和4例疑似致病性CNVs。按NT厚度2.5~2.9 mm、3.0~3.4 mm及≥3.5 mm将病例分3组,核型异常率分别为5.6%、7.9%和23.3%,芯片异常率分别为5.6%、11.1%和30.1%,随NT厚度增加,胎儿染色体异常率显著增加。当NT≥3.5 mm时,SNP array技术在NT增厚胎儿中共检出31例异常CNVs,与核型分析检出24例相比,检出率高6.8%,差异有统计学意义(P<0.05),而NT厚度为3.0~3.4 mm时,检出率仅提高3.2%,差异无统计学意义(P>0.05)。结论:NT增厚与染色体异常相关,随着NT厚度增加,胎儿染色体异常率显著增加。SNP array技术在染色体核型分析正常的NT增厚(NT≥3.5 mm)胎儿中可进一步检出染色体微缺失和(或)微重复,将遗传学病因的检出率提高6.8%,对临床遗传咨询具有重要价值。  相似文献   

4.
目的: 探讨22q11.2区微重复与临床表型之间的关系,为遗传咨询提供依据。方法: 对2015年2月至2017年3月在杭州市妇产科医院、丽水市妇幼保健院产前诊断中心接受羊水穿刺产前诊断,染色体微阵列分析(CMA)报告为22q11.2区微重复的8例胎儿的产前诊断指征、胎儿超声检查情况、染色体核型、父母CMA检测结果、妊娠结局、出生后的生长发育情况进行回顾性分析。结果: 8例胎儿产前血清学筛查结果21三体高风险6例、胎儿颈项皮肤皱褶(NF)增厚1例、母亲染色体平衡易位1例。胎儿超声检查结果胎儿NF增厚1例,胎儿侧脑室增宽1例,未发现异常6例。CMA检测结果提示,22q11.2区域微重复片段大小为651 kb~3.2 Mb。6例胎儿通过父母的CMA溯源,均来自正常表型的父母一方,2例父母拒绝溯源。引产2例,继续妊娠6例。继续妊娠胎儿出生时外观正常,随访至今最大年龄3.5岁,生长发育和心理发育正常5例,生长迟缓1例。结论: 本组22q11.2区微重复胎儿出生前后无特异的临床表现,均遗传自无任何异常症状的父母一方,提示对22q11.2微重复胎儿应当慎重处理。  相似文献   

5.
目的探讨染色体微阵列分析(chromosomal microarray analysis,CMA)技术在神经发育障碍性疾病(neurodevelopmental disailities,NDDs)患儿遗传学病因诊断中的临床应用价值。方法NDDs患儿采集外周血之后,提取基因组DNA并进行CMA检测,检测结果用ChASv3.0软件和相关信息学数据库进行分析。结果检测到染色体拷贝数变异患儿22例(22.00%,22/100),其中携带病理性变异及可能致病性变异患儿14例(14/100,14.00%),涉及17个致病性及可能致病性CNVs,包括14个微缺失位点(1q21.1q21.2、6p22.3、7q11.23、7q11.23、7q31.1、8p23.3p23.1、9q34.3、10q26.13q26.3、15q11.2q13.2、15q11.2q13.1、15q11.2q13.1、Xp22.32p22.31、Xp22.33p11.23、Xq21.1q28);3个微重复位点(2q36.3q37.3、9q34.12q34.3、8q24.23q24.3);携带临床意义未知变异的患儿8例(8/100,8.00%)。78例患儿未见明显染色体异常,样本的检测成功率为100%。结论染色体拷贝数变异是导致NDDs发生的重要遗传学因素之一。CMA检测能及时发现神经发育障碍性疾病患儿染色体异常,同时能够检测出传统染色体核型分析无法发现的大量微缺失或微重复,在检测的敏感性、特异性、可靠性等方面得到很大提高。  相似文献   

6.
目的探讨颈项透明层(NT)增厚(NT≥2.5 mm)与染色体异常及妊娠结局的关系及核型分析联合基因组拷贝数变异(CNV)测序在NT增厚胎儿中的应用价值。方法回顾性分析134例NT增厚胎儿资料,按NT厚度将其分为2.5 mm≤NT3.0 mm组(51例)、3.0 mm≤NT4.0 mm组(53例)、NT≥4.0 mm组(30例)。并按年龄分为高龄组(44例)与非高龄组(90例),统计分析胎儿染色体结果并统计妊娠结局。其中68例NT增厚胎儿同时进行核型分析和CNV测序,比较两者单独及联合应用异常核型检出率的差别。结果 NT增厚胎儿异常核型检出率为19.40%(26/134),2.5 mm≤NT3.0 mm、3.0 mm≤NT4.0 mm、NT≥4.0 mm组胎儿异常核型检出率分别为7.84%(4/51)、16.98%(9/53)和43.33%(13/30),三组比较差异有统计学意义(P0.05);高龄组与非高龄组异常核型检出率分别为43.18%(19/44)和7.78%(7/90),差异有统计学意义(P0.05)。核型、测序单独及联合应用异常核型检出率分别为17.65%(12/68)、17.65%(12/68)和20.59%(14/68)。108例NT增厚染色体正常胎儿中,11例尚未分娩,2例失访,其余95例胎儿中1例流产,1例胎死宫内,1例畸胎引产,这3例核型和测序结果均未见异常,NT值分别为3.6、3.9和3.3 mm,1例核型正常CNV测序检出Xp22.31重复1.70 Mb,该区域意义未明,孕妇选择引产,其余34例剖宫产,57例顺产;所有出生儿随访至1个月,除1例检出先天性心脏病外其余胎儿未见明显异常。结论胎儿NT增厚与染色体异常关系密切,且染色体异常风险随NT值及年龄增高而增高,CNV测序技术与染色体核型分析联合应用有利于异常核型的检出,NT增厚而核型正常的胎儿妊娠结局一般良好。  相似文献   

7.
目的探讨染色体微阵列分析(chromosomal microarry analysis, CMA)在染色体核型分析无法明确诊断病例中的临床应用价值。 方法回顾性分析我院自2014年9月至2016年4月因染色体核型分析不能明确诊断而进一步进行CMA的48例病例(34例羊水标本,14例外周血标本),对两种方法的检测结果进行比较。 结果48例病例中,核型分析提示13例为标记染色体,19例为衍生染色体,16例为染色体平衡易位。CMA共检出异常病例16例,异常率为33.33%。32例核型分析提示为标记染色体或衍生染色体的病例,CMA检测出大于5 Mb的缺失或重复16例,包括1例21-三体、2例XYY综合征及3例微重复/微缺失综合征(22q11重复综合征、Wolf-Hirschhorn综合征及15q26过度生长综合征)。16例核型分析为染色体平衡易位的病例,CMA均未发现阳性结果。 结论CMA可以明确定位核型分析发现的标记染色体或衍生染色体的来源,精确区分染色体不平衡易位和平衡易位。  相似文献   

8.
目的:对5例稽留流产绒毛进行遗传学检测,明确其病因和发生机制,为夫妇再次生育时复发风险评估及产前诊断提供依据。方法:应用Affymetrix CytoScan 750K染色体微阵列芯片(chromosomal microarray analysis,CMA)对5例稽留流产绒毛进行全基因组拷贝数变异(copy number variation,CNV)分析,同时根据检出CNV片段大小及家属意愿,对5对夫妇设计合理的家系验证方案,以明确1p36微缺失的来源。结果:CMA检测结果显示胎儿1在1p36.32p36.31存在1.75 Mb微缺失,胎儿父母常规核型分析和CMA检测均未见异常,但仍不排除父母一方是否为该片段插入易位携带者;胎儿2和3的CMA结果分别为1p36.13p36.12区带存在5.10 Mb微缺失和1p36.33p36.22区带存在9.21 Mb片段缺失,两者父母高分辨核型分析均未见异常,定制荧光原位杂交(fluorescence in situ hybridization,FISH)探针检测也未发现该位点的缺失、重复或易位重排等异常,应为新发异常。CMA提示胎儿4和5分别在1p36.33p36.22和1p36.33p36.23区带存在9.28 Mb和7.64 Mb微缺失,胎儿4父母高分辨核型正常,胎儿5父母拒绝进一步行家系验证。结论:本文在国内外首次报道了5例1p36缺失综合征引起的早孕期复发及偶发性流产,包括2例中间缺失和3例单纯末端缺失。CMA可发现流产胎儿隐匿性染色体亚显微结构变异,结合常规/高分辨核型分析、FISH、CMA等技术的优缺点,制定合理的家系验证方案,有助于明确染色体变异发生机制,对夫妻再孕时产前诊断和再发风险评估有重要价值。  相似文献   

9.
背景 胎儿鼻骨发育情况评估作为常规产前超声检查项目,是胎儿染色体检查的重要指标,近几年染色体微阵列分析技术(CMA)的应用使得产前胎儿染色体疾病的检查范围更广、准确度更高,在此基础上有必要对鼻骨发育异常和染色体异常之间的相关性重新进行总结,为临床提供参考。目的 探讨胎儿鼻骨发育异常或与其他产前筛查高危因素结合在预测胎儿染色体异常中的价值,以及CMA在胎儿鼻骨发育异常遗传学检测中的应用价值。方法 选取2016年12月-2020年1月于内蒙古自治区妇幼保健院进行产前超声检查并提示胎儿鼻骨缺失或发育不良的92例孕妇及胎儿为研究对象。收集其产检信息、遗传学检测结果及妊娠结局。遗传学检测方法包括染色体核型分析和CMA。结果 染色体核型分析检出染色体异常19例(20.7%),均为21-三体;CMA检出染色体异常25例(27.2%),包括21-三体19例,染色体微缺失微重复6例。孤立性与非孤立性鼻骨发育异常胎儿染色体异常发生率比较,差异无统计学意义(P>0.05)。与单纯孤立性鼻骨发育异常胎儿相比,孤立性鼻骨发育异常+颈项透明层(NT)增厚、孤立性鼻骨发育异常+血清学筛查(MSS)高风险、孤立性鼻骨发育异常+无创产前筛查(NIPT)高风险、孤立性鼻骨发育异常+2种及以上产前筛查高危因素胎儿染色体异常发生率均升高(P<0.05)。结论 鼻骨缺失或发育不良的胎儿染色体异常发生率较高,且与基因组变异有关;染色体核型分析、CMA结合其他产前筛查高危因素将有效提高染色体异常的检出率。CMA的应用为产前诊断提供了更多的染色体变异信息,建议所有类型的胎儿鼻骨缺失或发育不良进行染色体核型分析与CMA结合的遗传学检测。  相似文献   

10.
目的 探讨染色体核型分析结合单核苷酸多态性微阵列芯片(single nucleotide polymorphism array,SNP-Array)检测在妊娠早期胎儿颈项透明层(nuchal translucency,NT)增厚中的临床应用价值。方法 选取2017年5月至2022年6月于金华市妇幼保健院因产前超声提示NT增厚而就诊的223例孕妇为研究对象,经羊水穿刺抽取样本进行染色体核型分析和SNP-Array检测,对结果进行整理与分析。结果 胎儿染色体核型分析异常42例(18.8%),其中非整倍体数目异常32例(76.2%),结构异常7例(16.7%),嵌合体3例(7.1%);6例异常染色体核型分析结果与SNP-Array检测结果不符。SNP-Array检测结果异常50例(22.4%),36例检测结果与染色体核型分析结果一致,额外发现14例染色体有微缺失或微重复。随着NT值增大,染色体异常检出率上升,但不同NT值间的异常检出率比较差异无统计学意义(P>0.05)。NT增厚结合其他异常指标的染色体异常检出率显著高于单一NT增厚(P<0.01)。结论 NT增厚与胎儿异常染色体关系密切,染色体核型分析联合SNP-Array检测对异常染色体进行检测能够提高异常检出率,做到早发现、早干预,为临床遗传咨询提供帮助。  相似文献   

11.
Objective: To evaluatel the value of D-dimers in patients with acute aortic dissection (AAD). Methods: This study consisted of 16 patients with AAD and 27 non-AAD patients. Serum D-dimets were measured by Sta-Liatest D-DI immunoturbidimetric assay. Results: D-dimer level was higher (P < 0.001) in patients with AAD(7.91 ± 5.52 μg/ml) than that in non- AAD group(1.57±1.24 μg/ml). D-dimer was positive (>0.4 μg/ml) in all patients with AAD and in 10 control group patients (37%). Among patients with acute AAD, D-dimers tended to be higher in Stanford A than in Stanford B (8.67 ± 4.31 μg/ml vs. 3.24±1.27 μg/ml, P <0.01). D-dimer values tended to be higher in more extended disease(3.84 ± 1.65 μg/ml, 8.57 ± 3.58 μg/ml and 11.87 ± 5.69 μg/ml in thoracic aorta, thoracic and abdominal aorta, thoracic and abdominal aorta and iliacal arteries, respectively, P < 0.05 for both 8.57 ± 3.58 and 11.87 ± 5.69 vs. 3.84 ± 1.65 ). Including the control group into the analysis, we found a sensitivity of 100%, a negative predictive value of 100%, and a specificity of 66% and a positive predictive value of 64% for D-dimer in diagnosis of AAD in our patients with suspected AAD. Conclusion: D-dimer was elevated in patients with AAD. A negative D-dimer test result could be useful in excluding AAD.  相似文献   

12.
Objective: To set up a simple and reliable rat model of combined liver-kidney transplantation. Methods: SD rats served as both donors and recipients. 4℃ sodium lactate Ringer's was infused from portal veins to donated livers,and from abdominal aorta to donated kidneys, respectively. Anastomosis of the portal vein and the inferior vena cava (IVC) inferior to the right kidney between the graft and the recipient was performed by a double cuff method, then the superior hepatic vena cava with suture. A patch of donated renal artery was anastomosed to the recipient abdominal aorta. The urethra and bile duct were reconstructed with a simple inside bracket. Results: Among 65 cases of combined liver-kidney transplantation, the success rate in the late 40 cases was 77.5%. The function of the grafted liver and kidney remained normal. Conclusion: This rat model of combined liver-kidney transplantation can be established in common laboratory conditions with high success rate and meet the needs of renal transplantation experiment.  相似文献   

13.
目的:评价使用安心颗粒对急诊经皮冠状动脉介入术(PPCI)术后生活质量的影响.方法:将160例接受PPCI的急性ST段抬高型心肌梗死患者随机分为安心颗粒组(术前顿服安心颗粒8.8g,术后安心颗粒4.4 g/次,每日2次)和对照组(仅接受基础药物治疗).所有患者均服用阿司匹林、氯吡格雷和阿托伐他汀.分别在入院时、出院前1d、出院后180 d时,应用心肌梗死多维度量表(MIDAS)、中文版SF-36评价量表对患者生活质量评分.并观察术后30 d以内的出血并发症、血小板减少症发生情况.结果:入院时和出院前1d,两组患者的心肌梗死MIDAS、SF-36量表评分比较无差异(P>0.05);出院后180 d时,与对照组比较,安心颗粒组MIDAS、SF-36评分明显减低(P<0.05);组内与入院时比较,两组出院前1d、出院后180 d时,MIDAS、SF-36评分均降低(P<0.05).两组患者在随访期间均无大量出血、少量出血、重度和极重度血小板减少症发生,安心颗粒组有4例、对照组有7例发生不明显出血(P>0.05).两组发生轻度血小板减少症的患者数比较无差异(P>0.05).结论:PPCI使用安心颗粒,能改善急性ST段抬高型心肌梗死患者的生活质量,且不增加出血风险.  相似文献   

14.
Objective:To investigate the influences of urapidil and nicardipine on rabbit sinus function,atrio-ventricular node function and hemodynamics.Methods:Thirty-two Angora's rabbits were selected and randomly divided into four groups.U1 group:urapidil 0.25 mg/kg;U2 group:urapidil 0.5 mg/kg;N1 group:nicardipine 10 μg/kg;N2 group:nicardipine 20 μg/kg.All these medicine were administrated within 30 seconds.Measurements were taken before and after the administration of urapidil or nicardipine for the following data:mean blood pressure(MAP),heart rate(HR),sino-atrial conduction time(SACT),maximal sinoatrial recovery time(SNRTmax)corrected sinus node recovery time(CSNRT),index of sinus node recovery time(SNRTI),Wenckebach A-V conduction frequency (WB),and P-R interval.Results:Significant MAP and HR changes were identified in all of the four groups before and after administration of both urapidil and nicardipine.No significant changes could be found in the rest of the parameters.Intergroup analysis showed that SACT and CSNRT of N1 and N2 groups were shorter than those of the U2 group(P<0.01);the MAP decreased(P<0.01)and the HR increased drastically(P<0.01).Conclusions:Neither urapidil(0.25 mg/kg,0.5 mg/kg)nor nicardipine(10μg/kg,20μg/kg)has any significant influence on rabbit sinus function or rabbit atrio-ventricular node function.Nicardipine could be a better choice than urapidil for parafunctional sinus node patients.  相似文献   

15.
Objective:To investigate the gene expression of osteoprotegerin(OPG) and osteoclast differentiation factor(ODF) in the bone tissue of patients with hip fracture due to osteoporosis. Methods:OPGmRNA and ODFmRNA in the bone tissue in 50 cases of osteoporosis sufferers(over 50 years old) with hip fracture(Observer Group) and 30 cases of hip facture sufferers with no osteoporosis(Control group) were analyzed with the Semi-Quantitative RT-PCR method. Results:The mRNA expressed of ODF, OPG were both high in the patients with hip fracture. In the control group, the expression of OPG mRNA was observed, while the expression of ODF mRNA was very slight. Conclusion:Aged patients contained all signals including OPG, ODF that are essential for inducing osteoclastogenesis and promoting bone resorption.  相似文献   

16.
Objective:To investigate the clinical features, pathological characteristics and immunophenotype of solid-pseudopapillary tumor of the pancreas(SPTP). Methods:Nine surgically treated cases of SPTP were retrospectively reviewed. Hematoxylin and Eosin(HE) staining and immunohistochemical staining were used to analyze all cases, and the general clinical data was collected. Results:Six patients were asymptomatic except for a palpable mass. Two patients complained of vague-epigastric pain. One patient appeared jaundice. The tumor was encapsulated and solid tissues alternately with cystic tissues. Histologically, the histological structure of solid portion was pseudopapillary with a fibrovascular core. Tumor cells were uniform and medium-sized which were arranged in sheets ets or nests or pseudopapillary patterns. Immunohistochemical studies demonstrated that SPTP proved positive in vimentin(9/9 cases), AAT(9/9 cases), NSE(9/9 cases), ACT(7/9 cases), CK20(2/9 cases), CgA(1/9 cases), S-100(3/gcases), PR(4/gcases), Syn(3/9 cases) and CD56(5/9cases), negative in CEA and ER. Conclusion:SPTP is a tumor predominantly occurring in young women frequently without special symptoms. This tumor has various characteristical histological patterns with different immunophenotype.  相似文献   

17.
In recent years, the author of this essay has applied electro-acupuncture combined with the trigger point needle-embedding for treatment of primary trigeminal neuralgia in 31 cases, yielding satis- factory results as reported in the following.  相似文献   

18.
Objective: To explore the role of matrix metalloproteinase-1,2 (MMP-1, MMP-2) and tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in endometriosis. Methods: The eutopic and ectopic endometria from 40 subjects suffering from endometriosis and regular.endometria from 40 subjects (excluding endometriosis) were collected and examined by in situ hybridization technology and western blot assay. Results: Both expressions of MMP-1 and -2 were stronger in ectopic endometrium and eutopic endometrium than in normal endometrium. On the contrary, the expression of TIMP-1 in ectopic endometrium and eutopic endometrium was lower. The differences were significant (P 〈 0.01 ). Moreover, there was no relationship among the expressions of MMP-1, 2 and TIMP-1 in ectopic endometrium. Conclusion: The expressions of MMP-1, 2 and TIMP-1 lose balance and lack of periodic changes in ectopic endometrium , which explains the biological invasive behavior of endometriosis. It was suggested-that regulating the balance between the MMPs and TIMP-1 should be an ideal therapeutic target to endometriosis.  相似文献   

19.
Prof. SHI Da-zhuo, Ph.D., male, was born on March 20, 1960. Prof. SHI entered the Ph.D. program in 1990 at the China Academy of Chinese Medical Sciences under the supervision of Prof. CHEN Ke-ji, majoring in the treatment of cardiovascular diseases. After receiving his Ph.D. degree in 1993, Prof. SHI started working at the Cardiovascular Center in Xiyuan Hospital affiliated to China Academy of Chinese Medical sciences.  相似文献   

20.
《中国结合医学杂志》2008,14(2):159-159
The 6th National General Congress of Chinese Association of Integrative Medicine (CALM) was convened at 19-20, April 2008 in Beijing. Academician CHEN Zhu, the minister of Ministry of Health indicated at the congress that the integration of Chinese and Western medicine is very well in keeping with the situation of our country and the general rule of development in medical science; and as a good integration of Chinese medicine and Western medicine, it is mutually beneficial and advantageous to both of them. Seeing the creativity shown in integrative medical investigation in theoretic and methodological sides, we should and must persist in and develop it.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号